동물 백신 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Animal Vaccines Market size is expected to reach USD 20.15 Billion in 2034 from USD 10.73 Billion (2025) growing at a CAGR of 7.26% during 2026-2034.

The global animal vaccines market is experiencing strong growth due to increasing demand for animal health products and the need to prevent infectious diseases in livestock and companion animals. Vaccination plays a critical role in ensuring food safety, improving animal productivity, and reducing the spread of zoonotic diseases. The expansion of the livestock industry and growing awareness of animal health are key factors driving market growth.

Key drivers include rising global demand for animal-based food products, increasing investments in veterinary healthcare, and government initiatives promoting vaccination programs. Technological advancements in vaccine development, including recombinant and DNA vaccines, are improving efficacy and safety. Additionally, the growing focus on disease prevention is encouraging widespread adoption of vaccination practices.

Looking ahead, the market is expected to benefit from continuous innovation and the development of advanced vaccine technologies. The integration of digital monitoring tools and improved distribution systems will enhance accessibility and effectiveness. As global demand for animal health solutions continues to rise, the animal vaccines market is set for strong and sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Animal Type

• Livestock Animals (Poultry, Cattle, Swine, Aquaculture, Sheep And Goats)
• Companion Animals (Canine, Feline, Equine, Avian)

By Vaccine Type

• Attenuated Live Vaccine
• Conjugate Vaccine
• Inactivated Vaccine
• Dna Vaccine
• Recombinant Vaccine
• Other Vaccine Types

By Application

• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Fungal Infections
• Other Applications

By Route Of Administration

• Injection Vaccines
• Oral Vaccines
• Immersion/Spray Vaccines

By Distribution Channel

• Veterinary Hospital Pharmacies
• Retail Pharmacies
• E-Commerce

COMPANIES PROFILED

• Zoetis, Merck Animal Health, Boehringer Ingelheim, Elanco, Virbac, Ceva Sant Animale, Dechra Pharmaceuticals, Neogen Corporation, Vetoquinol, Brilliant Bio Pharma, Indian Immunologicals, Hipra, Henry Schein, Bioveta, Durvet
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANIMAL VACCINES MARKET: BY ANIMAL TYPE 2022-2034 (USD MN and Million Doses)

• 4.1. Market Analysis, Insights and Forecast Animal Type
• 4.2. Livestock Animals (Poultry, Cattle, Swine, Aquaculture, Sheep And Goats) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 4.3. Companion Animals (Canine, Feline, Equine, Avian) Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 5. GLOBAL ANIMAL VACCINES MARKET: BY VACCINE TYPE 2022-2034 (USD MN and Million Doses)

• 5.1. Market Analysis, Insights and Forecast Vaccine Type
• 5.2. Attenuated Live Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.3. Conjugate Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.4. Inactivated Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.5. Dna Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.6. Recombinant Vaccine Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 5.7. Other Vaccine Types Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 6. GLOBAL ANIMAL VACCINES MARKET: BY APPLICATION 2022-2034 (USD MN and Million Doses)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Bacterial Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.3. Viral Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.4. Parasitic Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.5. Fungal Infections Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 6.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 7. GLOBAL ANIMAL VACCINES MARKET: BY ROUTE OF ADMINISTRATION 2022-2034 (USD MN and Million Doses)

• 7.1. Market Analysis, Insights and Forecast Route Of Administration
• 7.2. Injection Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.3. Oral Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 7.4. Immersion/Spray Vaccines Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 8. GLOBAL ANIMAL VACCINES MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN and Million Doses)

• 8.1. Market Analysis, Insights and Forecast Distribution Channel
• 8.2. Veterinary Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 8.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)
• 8.4. E-Commerce Estimates and Forecasts By Regions 2022-2034 (USD MN and Million Doses)

Chapter 9. GLOBAL ANIMAL VACCINES MARKET: BY REGION 2022-2034 (USD MN and Million Doses)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 9.2.1 By Animal Type
  • 9.2.2 By Vaccine Type
  • 9.2.3 By Application
  • 9.2.4 By Route Of Administration
  • 9.2.5 By Distribution Channel
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 9.3.1 By Animal Type
  • 9.3.2 By Vaccine Type
  • 9.3.3 By Application
  • 9.3.4 By Route Of Administration
  • 9.3.5 By Distribution Channel
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 9.4.1 By Animal Type
  • 9.4.2 By Vaccine Type
  • 9.4.3 By Application
  • 9.4.4 By Route Of Administration
  • 9.4.5 By Distribution Channel
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 9.5.1 By Animal Type
  • 9.5.2 By Vaccine Type
  • 9.5.3 By Application
  • 9.5.4 By Route Of Administration
  • 9.5.5 By Distribution Channel
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Million Doses)
  • 9.6.1 By Animal Type
  • 9.6.2 By Vaccine Type
  • 9.6.3 By Application
  • 9.6.4 By Route Of Administration
  • 9.6.5 By Distribution Channel
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL ANIMAL VACCINES INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Zoetis
  • 11.2.2 Merck Animal Health
  • 11.2.3 Boehringer Ingelheim
  • 11.2.4 Elanco
  • 11.2.5 Virbac
  • 11.2.6 Ceva Sante Animale
  • 11.2.7 Dechra Pharmaceuticals
  • 11.2.8 Neogen Corporation
  • 11.2.9 Vetoquinol
  • 11.2.10 Brilliant Bio Pharma
  • 11.2.11 Indian Immunologicals
  • 11.2.12 Hipra
  • 11.2.13 Henry Schein
  • 11.2.14 Bioveta
  • 11.2.15 Durvet